Expression of 14-3-3γ in patients with breast cancer: correlation with clinicopathological features and prognosis.

[1]  A. Aitken,et al.  14-3-3 proteins : a highly conserved widespread family of eukaryotic proteins , 2003 .

[2]  R Akita,et al.  Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. , 1993, Cancer research.

[3]  G. Landes,et al.  Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.

[4]  M. Toyota,et al.  Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. , 2000, Cancer research.

[5]  岩田 徳和.  Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2001 .

[6]  B. Gusterson,et al.  Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. , 2002, Cancer research.

[7]  C. Bosman,et al.  Fatty acid synthase expression in melanoma , 2003, Journal of cutaneous pathology.

[8]  D. Morrison,et al.  Unlocking the code of 14-3-3 , 2004, Journal of Cell Science.

[9]  C. MacKintosh,et al.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.

[10]  H. Hermeking,et al.  Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression , 2004, Oncogene.

[11]  Guan-Tarn Huang,et al.  Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. , 2005, Journal of proteome research.

[12]  A. Aitken.  14-3-3 proteins: a historic overview. , 2006, Seminars in cancer biology.

[13]  M. Dai,et al.  14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation , 2006, The EMBO journal.

[14]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[15]  Jesse D. Martinez,et al.  Overexpression of 14‐3‐3γ causes polyploidization in H322 lung cancer cells , 2007 .

[16]  Travis L. Rice-Stitt,et al.  14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients , 2008, Cancer Immunology, Immunotherapy.

[17]  K. Baek,et al.  Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. , 2008, Biochemical and biophysical research communications.

[18]  K. Baek,et al.  14-3-3γ Is Stimulated by IL-3 and Promotes Cell Proliferation1 , 2009, The Journal of Immunology.

[19]  K. Baek,et al.  14-3-3 gamma is stimulated by IL-3 and promotes cell proliferation. , 2009, Journal of immunology.

[20]  J. Liou,et al.  Cyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta --> 14-3-3epsilon pathway. , 2009, Methods in molecular biology.

[21]  Hua Guo,et al.  14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. , 2009, Cancer research.

[22]  Zhuchu Chen,et al.  Inactivation of 14‐3‐3 σ by promoter methylation correlates with metastasis in nasopharyngeal carcinoma , 2009, Journal of cellular biochemistry.

[23]  Jesse D. Martinez,et al.  14-3-3γ Induces Oncogenic Transformation by Stimulating MAP Kinase and PI3K Signaling , 2010, PloS one.

[24]  Matthew E. Kahn,et al.  Economic Conditions Predict Prevalence of West Nile Virus , 2010, PloS one.